FindTrial
Sign In

Optimalisation of fluid balance with Flowtrac/Vigileo during the HIPEC procedure

Optimalisation of fluid balance with Flowtrac/Vigileo during the HIPEC procedure - Optifluid

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON36111
Enrollment
32
Registered
2011-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

circulatie bowel cancer carcinomatosis peritonei

Interventions

None listed

Sponsors

Sint Antonius Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: age > 18 years carcinomatosis peritonei Hipec procedure

Exclusion criteria

Exclusion criteria: no sinusrhythm (No validity of Flowtrac) Left ventricle dysfunction (severe LVEF

Design outcomes

Primary

MeasureTime frame
Reducing positive fluid balance 30%. Differences in plasma electrolytes and differences in measured responses inflammattoire including cytokines and CRP.—

Secondary

MeasureTime frame
Secondary endpoints: use of inotropes and diuretics, observation of occurrence of complications, duration of mechanical ventilation and ICU stay.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)